Evidence map›Paper›PMID 33363892›Full record

ArticleClinical case reports2020

Two cases of type 2 diabetes mellitus successfully treated with probiotics.

Néstor Cardinali, Carlos Bauman, Facundo Rodriguez Ayala, Roberto Grau

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Probiotic properties ofFrontiers in microbiology · 2023
    Article
  6. Article
  7. Safety Evaluation and Anti-Inflammatory Efficacy ofInternational journal of molecular sciences · 2022
    Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Néstor CardinaliInstituto Cardinali de Nutrición Rosario Argentina.
Carlos BaumanFacultad de Ciencias Bioquímicas y Farmacéuticas Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) Universidad Nacional de Rosario Rosario Argentina.
Facundo Rodriguez AyalaDepartamento de Micro y Nanotecnología Instituto de Nanociencia y Nanotecnología - Comisión Nacional de Energía Atómica y CONICET Buenos Aires Argentina.
Roberto GrauFacultad de Ciencias Bioquímicas y Farmacéuticas Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) Universidad Nacional de Rosario Rosario Argentina.ORCID https://orcid.org/0000-0002-6496-3696
Consejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota, and particularly probiotic bacteria, has emerged as a promising and novel intervention to fight the looming worldwide diabetes epidemic when combined with the appropriate medication. Herein, we report two cases of patient with type 2 diabetes refractory to conventional therapy that showed notable improvement after probiotic intervention.

Indexed as

Bacillus subtilisinsulin resistanceprobioticstype 2 diabetes mellitus

Identifiers

PMID33363892
PMCPMC7752325
OpenAlexW3088978571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.